UK's Glaxo Smith Kline Aims to Market First Malaria Vaccine
October 8, 2013
Reuters / Powered by NewsLook.com
British drug maker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed it significantly cut cases of the disease in African children. As Joanna Partridge reports it will be welcome news for a UK company recently battered by a corruption scandal in China.
AFP (Apr. 24, 2014) World Malaria Day is commemorated every year on April 25 and recognizes global efforts to control malaria. Seasonal malaria chemoprevention is a new prevention strategy for Niger. Duration: ... watch video
AFP (Oct. 8, 2013) Experts in Africa, the continent worst-hit by malaria, reacted with optimism but also caution on Tuesday at hopes that the first vaccine against the killer disease may soon reach the market. ... watch video
Reuters - Innovations Video Online (May 2, 2016) An over the counter kit used to test for malaria at home using a patient's urine could make a substantial impact in the global fight to eliminate malaria by 2030.
Video provided by ... watch video
Reuters - News Video Online (Apr. 24, 2015) The world's first anti-malaria vaccine could get the go-ahead for use in Africa from October if approved by international regulators. Paul Chapman reports.
Video provided by ... watch video
AFP (July 24, 2015) The world's most advanced malaria vaccine got the nod Friday from European regulators, despite mixed trial results, for eventual use in children in African countries plagued by the killer ... watch video
Reuters (Aug. 5, 2013) Israeli drug company SciVac has developed a third-generation vaccine for Hepatitis B, a virus that kills more than half a million people each year. The company says the vaccine has the potential to ... watch video
Oct. 21, 2016 For the first time, scientists have revealed the mechanics of how bacteria build up slimy masses, called biofilms, cell by cell. When encased in biofilms in the human body, ... read more
Oct. 19, 2016 Study shows no link between appetite and calorie consumption. These findings highlight problems with health claims made by food industry, and more research is needed to see what influences calories ... read more
Oct. 19, 2016 Researchers may have found a clue to why some women experience hot flashes or night sweats and others don’t: gene variants affecting a brain receptor regulating estrogen release and is present ... read more
Oct. 19, 2016 As football and soccer become year-round sports, their popularity accounts for more concussions and head injuries. This has parents, athletes and head injury experts sounding the alarm of long-term ... read more
Oct. 18, 2016 Stem cell transplantation is a promising strategy for restoring eyesight resulting from corneal damage, but tissue grafts must contain a high percentage of stem cells for clinical success. Now a ... read more
Apr. 12, 2016 Although the World Health Organization decided not to recommend the use of RTS,S/AS01, the most advanced malaria vaccine candidate that is in development, in infants within the Expanded Programme of ... read more
Apr. 23, 2015 The first malaria vaccine candidate (RTS,S/AS01) to reach phase 3 clinical testing is partially effective against clinical disease in young African children up to 4 years after vaccination, according ... read more
July 29, 2014 A vaccine previously shown to reduce malaria in young infants and children reduces larger numbers of malaria cases in areas of higher malaria transmission, according to results from an ongoing ... read more
May 7, 2014 Although malaria kills some 600,000 African children each year, most cases of the mosquito-borne parasitic disease in children are mild. Repeated infection does generate some immunity, and episodes ... read more